Holiferm develops holistically improved fermentation technology for massive economic improvements.
Holiferm has raised $23.2M in total funding. The most recent round was Series B. The last funding was announced in December 2023.
Holiferm's investors include Clean Growth Fund, Greater Manchester Combined Authority, Rhapsody Venture Partners, ICOS Capital Management, Biotechnology and Biological Sciences Research Council.
Holiferm is headquartered in Manchester, United Kingdom.
Holiferm develops holistically improved fermentation technology for massive economic improvements.
Holiferm is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Holiferm — Funding & Investors." VCBacked, December 6, 2023, https://www.vcbacked.co/company/holiferm. Accessed July 21, 2026.
VCBacked. (2023). Holiferm — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/holiferm
{{cite web |title=Holiferm — Funding & Investors |url=https://www.vcbacked.co/company/holiferm |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated